Bald neuer Katalog: sichern Sie sich schon vorab Ihre persönlichen Merklisten im Nutzerkonto: Anleitung.

Volltext-Artikel, E-Books und Literaturhinweise aus dem EBSCO Discovery Service

"Artikel & mehr" berücksichtigt nur einen Teil der für die Bibliothek der Frankfurt UAS verfügbaren Datenbanken. Zur Übersicht in DBIS

Ergebnis verändern

einschränken: Volltextzugriff; Academic (peer-reviewed) journals
erweitern: Auch Volltexte der Artikel durchsuchen; Verwandte Themen suchen

Publikationstyp

Thema

erschienen in

Verlag

Geographic terms

Sprache

Datenbank

Erscheinungsjahr

Von:

Bis:

Treffer 1 - 25 von 546, Suchdauer: 0.91s

12 3 4 5 6 7 8 9 10 11 weiter »

1
Breast cancer prevention in patients with gBRCA-mutated ovarian cancer

von Amann, Niklas ; Krückel, Annika ; Brückner, Lena ; et al.

Journal of Cancer Research and Clinical Oncology. 152(6)
- Zum Volltext in PubMed Central
Merkliste

2
Alpelisib and Fulvestrant in PIK3CA-mutated hormone receptor-positive HER2-negative advanced breast cancer included in the German PRAEGNANT trial

von Hörner, Manuel ; Tretschock, Lara M. ; John, Nelson ; et al.

Breast Cancer Research and Treatment. 217(1)
- Zum Volltext (via ReDI)
Merkliste

3
Lessons learned from a candidate gene study investigating aromatase inhibitor treatment outcome in breast cancer

von Hoppe, Reiner ; Winter, Stefan ; Lo, Wing-Yee ; et al.

npj Breast Cancer. 11(1)
- Zum Volltext in PubMed Central
Merkliste

4
Evaluation and feasibility of diagnostic heatflow imaging in patients with palpable breast lesions: a pilot study

von Pöschke, Patrik ; Boese, Axel ; Seitz, Katharina ; et al.

Archives of Gynecology and Obstetrics. 312(4):1107-1115
- Volltextverfügbarkeit prüfen (via ReDI)
Merkliste

5
Integration von Komplementärmedizin in die Uroonkologie

von Hack, Carolin C. ; Seitz, Katharina ; Thederan, Imke ; et al.

Die Urologie: Organ der Deutschen Gesellschaft für Urologie Organ des Berufsverbandes der Deutschen Urologie. 64(9):925-932
- Zum Volltext (via ReDI)
Merkliste

6
Quality of care before and after initial certification at a German certified hereditary breast and ovarian cancer center

von Amann, Niklas ; Hörner, Manuel ; Spannring, Henrik ; et al.

Journal of Cancer Research and Clinical Oncology. 152(1)
- Zum Volltext in PubMed Central
Merkliste

7
Prediction of pathological complete response after neoadjuvant chemotherapy for HER2-negative breast cancer patients with routine immunohistochemical markers

von Häberle, Lothar ; Erber, Ramona ; Gass, Paul ; et al.

Breast Cancer Research. 27(1)
- Zum Volltext in PubMed Central
Merkliste

8
Impact of risk and lifestyle factors on therapy goals in the treatment of breast cancer and gynecological cancer patients with integrative medicine

von Seitz, Katharina ; Theuser, Anna-Katharin ; Antoniadis, Sophia ; et al.

Archives of Gynecology and Obstetrics. 311(6):1683-1695
- Volltextverfügbarkeit prüfen (via ReDI)
Merkliste

9
Breast cancer risk genes affecting individual radiosensitivity

von Vogel, Ramona K. G. ; Amann, Niklas ; Kassem, Tara Zuhair ; et al.

Schlagworte: info:eu-repo/classification/ddc
- View full text via BASE
Merkliste

10
Prognostic impact of the choice of chemotherapy after first-line CDK4/6 inhibitor therapy in patients with metastatic hormone receptor-positive, HER2-negative breast cancer

von Michel, Laura L. ; Ziegler, Philipp ; Kreis, Philipp ; et al.

In European Journal of Cancer 9 September 2025 227
- View full text via DOI
Merkliste

11
Malignant upgrade in lesions of uncertain malignant potential in the breast (B3 lesions) – is open excision always necessary?

von Heindl, Felix ; Schiel, Janina ; Hack, Carolin C. ; et al.

Breast Cancer Research and Treatment. 211(1):173-183
- Zum Volltext (via ReDI)
Merkliste

12
Microdochectomy for patients with nipple discharge and the risk of associated breast cancer

von Amann, Niklas ; Gökce, Zeynep ; Hack, Carolin C. ; et al.

BMC Surgery. 26(1)
- Zum Volltext in PubMed Central
Merkliste

13
Impact of CCND1 amplification on the prognosis of hormone receptor–positive, HER2-negative breast cancer patients—correlation of clinical and pathological markers

von Hanf, Dorothea ; Fasching, Peter ; Gass, Paul ; et al.

Breast Cancer Research and Treatment. 210(1):125-134
- Zum Volltext (via ReDI)
Merkliste

14
Comparative assessment of breast volume using a smartphone device versus MRI

von Behrens, Annika S. ; Huebner, Hanna ; Häberle, Lothar ; et al.

Breast Cancer. 32(1):166-176
- Zum Volltext (via ReDI)
Merkliste

15
PARP inhibition with olaparib and talazoparib for HER2-negative advanced breast cancer—Results from the prospective PRAEGNANT registry

von Hörner, Manuel ; Hartkopf, Andreas ; John, Nelson ; et al.

npj Breast Cancer. 12(1)
- Zum Volltext in PubMed Central
Merkliste

16
Genetic tumor syndromes in female cancer: insights into inherited cancer predisposition and clinical implications

von Krückel, Annika ; Gocke, Julia ; Hörner, Manuel ; et al.

Archives of Gynecology and Obstetrics. 313(1)
- Volltextverfügbarkeit prüfen (via ReDI)
Merkliste

17
Prognostic impact of selection criteria of current adjuvant endocrine therapy trials NATALEE and monarchE in postmenopausal HRpos/HER2neg breast cancer patients treated with upfront letrozole

von Fasching, Peter A. ; Hack, Carolin C. ; Nabieva, Naiba ; et al.

In European Journal of Cancer September 2024 209
- View full text via DOI
Merkliste

18
Correlation of RANK and RANKL with mammographic density in primary breast cancer patients

von Wunderle, Marius ; Heindl, Felix ; Behrens, Annika S. ; et al.

Archives of Gynecology and Obstetrics. 310(2):1223-1233
- Zum Volltext (via ReDI)
Merkliste

19
Initial experience with a next-generation low-field MRI scanner: Potential for breast imaging?

von Dietzel, Matthias ; Laun, Frederik B. ; Heiß, Rafael ; et al.

In European Journal of Radiology April 2024 173
- View full text via DOI
Merkliste

20
The impact of physical activity on progression-free and overall survival in metastatic breast cancer based on molecular subtype

von Ziegler, Philipp ; Hartkopf, Andreas D. ; Wallwiener, Markus ; et al.

BMC Cancer. 24(1)
- Zum Volltext in PubMed Central
Merkliste

21
Pembrolizumab in combination with nab-paclitaxel for the treatment of patients with early-stage triple-negative breast cancer – A single-arm phase II trial (NeoImmunoboost, AGO-B-041)

von Fasching, Peter A. ; Hein, Alexander ; Kolberg, Hans-Christian ; et al.

In European Journal of Cancer May 2023 184:1-9
- View full text via DOI
Merkliste

22
Invasive disease-free and overall survival after (neo)adjuvant chemotherapy in postmenopausal patients with hormone receptor-positive, HER2-negative early breast cancer treated with upfront letrozole : experiences from the phase IV PreFace trial

von Beierlein, Milena ; Häberle, Lothar ; Nabieva, Naiba ; et al.

Schlagworte: ddc:610
- View full text via BASE
Merkliste

23
Validation of the Questionnaire for the Structured Assessment of the Use of Complementary Medicine Methods and Procedures in Patients from the S3 Guideline Complementary Medicine in Oncology and Practical Use of it in Patients with Gynecological Cancer

von Seitz, Katharina ; Theuser, Anna-Katharin ; Hack, Carolin C. ; et al.

Geburtshilfe und Frauenheilkunde ; volume 86, issue 01, page 35-44 ; ISSN 0016-5751 1438-8804
- View full text via BASE
Merkliste

24
Correction: Comparative assessment of breast volume using a smartphone device versus MRI

von Behrens, Annika S. ; Huebner, Hanna ; Häberle, Lothar ; et al.

Breast Cancer ; volume 32, issue 3, page 615-615 ; ISSN 1340-6868 1880-4233
- View full text via BASE
Merkliste

25
Cross-sectional study on user requirements for developing a digital patient navigator app

von Seitz, Katharina ; Langbein, Manuela ; Goossens, Chloë ; et al.

DIGITAL HEALTH ; volume 11 ; ISSN 2055-2076 2055-2076
- View full text via BASE
Merkliste

12 3 4 5 6 7 8 9 10 11 weiter »

Sie haben nicht gefunden, wonach Sie gesucht haben? Diese Services können Ihnen weiterhelfen.
Hilfe & Kontakt ǀ Fernleihe | Hilfe zur Fernleihe ǀ Literaturvorschlag| Literaturvorschlag